ClinicalTrials.Veeva

Menu

Improving Management of Post-partum Haemorrhage With Quantra® System (Quantralab)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Post Partum Haemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT05336838
RECHMPL21_0729

Details and patient eligibility

About

Post partum haemorrhage is a concerning situation in maternity wards, though it is not the first cause of maternal mortality anymore.

It has been already shown that low fibrinogen level is a major predictive factor of massive bleeding after delivery.

In this situation, the early knowledge of fibrinogen level could enhance care of women experiencing post partum haemorrhage.

In a cohort of women suffering from post partum haemorrhage, this study will evaluate whether assessing fibrinogen level would be faster using the Quantra® system than the standard coagulation test.

Enrollment

60 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Women ≥ 18 years old Experiencing post partum haemorrhage ≥ 500 mL Within 24 hours after delivery

Exclusion criteria

  • Previous anemia ≤ 7g/dL
  • Known bleeding disorders
  • Ongoing antiplatelets treatment
  • Ongoing anticoagulant treatment

Trial contacts and locations

0

Loading...

Central trial contact

Jessie Grenié, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems